SCHEMBL29659565

SCHEMBL29659565

CN(C)CCNc1nc(NCc2ccco2)c2ncn(C3CCCCO3)c2n1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 1/20 0.54
▸ FLT3 P36888 3/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ CDK2 P24941 6/20 0.46
▸ CCNE1 P24864 5/20 0.46
▸ YTHDC1 Q96MU7 1/20 0.46
▸ CDK1 P06493 5/20 0.44
▸ CSNK1A1 P48729 1/20 0.43
▸ CSNK1D P48730 1/20 0.43
▸ CDK7 P50613 1/20 0.43
▸ CCNH P51946 1/20 0.43
▸ MNAT1 P51948 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.42
▸ CCNB2 O95067 1/20 0.40
▸ CCNB1 P14635 1/20 0.40
▸ CCNB3 Q8WWL7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20547180 1.00 SRC (0.54) SRCFLT3NPC1RAB9ASMN1; SMN2
SCHEMBL20547441 0.97 SRC (0.53) SRCFLT3NPC1RAB9ASMN1; SMN2
SCHEMBL30675136 0.89 SMN1; SMN2 (0.51) FLT3NPC1RAB9ASMN1; SMN2CDK2
SCHEMBL20547610 0.89 NPC1 (0.52) FLT3NPC1RAB9ASMN1; SMN2CDK2
SCHEMBL29659648 0.89 NPC1 (0.52) FLT3NPC1RAB9ASMN1; SMN2CDK2
SCHEMBL20547188 0.88 YTHDC1 (0.55) FLT3NPC1RAB9ASMN1; SMN2CDK2
SCHEMBL29659534 0.88 YTHDC1 (0.55) FLT3NPC1RAB9ASMN1; SMN2CDK2
SCHEMBL20547186 0.86 NPC1 (0.52) FLT3NPC1RAB9ASMN1; SMN2CDK2
SCHEMBL29659624 0.86 NPC1 (0.52) FLT3NPC1RAB9ASMN1; SMN2CDK2
SCHEMBL20547474 0.86 FLT3 (0.49) FLT3NPC1RAB9ASMN1; SMN2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3615535-B1 9-(2-OXACYCLOALKYL)-9H-PURINE-2,6-DIAMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SKIN DISORDERS UNIV PALACKEHO (CZ) 2022-06-15 — — EP disclosed
Send feedback